ASH Ends With Consistent Kite CAR-T Data, Some Hope For Juno

Kite reported interim results for KTE-C19 from the ZUMA-1 study that showed efficacy consistent with earlier results without the deaths from neurotoxicity that have plagued Juno, but Juno’s latest CAR-T offering may carry fewer safety concerns.

More from Anticancer

More from Therapy Areas